Antimanic Agents - Research News and Information

Thursday, January 08, 2009

Adjunctive psychotherapy for bipolar disorder: state of the evidence.

13 Sep 2008 OBJECTIVE: Psychotherapy has long been recommended as adjunctive to pharmacotherapy for bipolar disorder, but it is unclear which interventions are effective for which patients, over what intervals, and for what domains of outcome. This article ... Read more...

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.

30 Aug 2008 On the basis of 3-week studies, lithium and valproate are both recommended for first-line treatment of acute mania. It is, however, also important to demonstrate that antimanic efficacy can be maintained. This study has been designed to compare the ... Read more...

Lithium overdose with electrocardiogram changes suggesting ischemia.

30 Aug 2008 BACKGROUND: Lithium toxicity is associated with electrocardiogram (ECG) changes, but changes suggestive of an ST segment elevation myocardial infarction have not been reported. CASE REPORT: A 46-year-old incarcerated man suffering from diabetes, ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Antimanic Agents'

These are the very latest articles for this heading:

• Bipolar drug development: are we getting closer to the real world? 29 Sep 2008
• Aggression, suicide, and lithium treatment. 29 Sep 2008
• Adjunctive psychotherapy for bipolar disorder: state of the evidence. 13 Sep 2008
• A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. 30 Aug 2008
• Lithium overdose with electrocardiogram changes suggesting ischemia. 30 Aug 2008
• The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges. 30 Aug 2008
• Valproate: do formulations matter? 30 Jul 2008
• Toxic interaction between valproate and oxcarbazepine: a case detected by the free valproate level. 30 Jul 2008
• Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. 30 Jul 2008
• Case records of the Massachusetts General Hospital. Case 24-2008. A 35-year-old woman with postpartum confusion, agitation, and delusions. 29 Jul 2008
• Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? 21 Jul 2008
• Lithium-induced suppression of transcription repressor NRSF/REST: effects on the dysfunction of neuronal differentiation by ethanol. 15 Jul 2008
• Valproate for schizophrenia. 14 Jul 2008
• Central pontine and extra-pontine myelinolysis: a complication of lithium toxicity in a pregnant woman. 30 Jun 2008
• Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy. 29 Jun 2008
• Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet. 29 Jun 2008
• Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. 29 Jun 2008
• Thyrotoxicosis after iodine contrast medium administration: rapid mood swing to mania and subsequent psychotic depression in a patient with bipolar disorder during lithium therapy. 29 Jun 2008
• The proximal prodrome to first episode mania--a new target for early intervention. 29 Jun 2008
• Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change. 29 Jun 2008

See a longer list of these articles.

Technical information about 'Antimanic Agents'

Definition: Agents that are used to treat bipolar disorders or mania associated with other affective disorders.

Registry Number: 0

Descriptor UI: D018692

Alternative terms: Antimanic Agents; Agents, Antimanic; Antimanic Drugs; Drugs, Antimanic; Antimanics;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.277.950.025; D27.505.954.427.210.950.025; D27.505.954.427.700.872.025;

History Note: 95

Technical Notes: tranquilizing agents; consider also BIPOLAR DISORDER /drug ther